drugset / Trial / NCT05718024

Night-time Dexmedetomidine-esketamine Infusion and Sleep Quality in ICU Patients

NCT05718024

Phase 4 Completed 174 enrolled Peking University First Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

Dexmedetomidine and ketamine are both suggested for sedation and analgesia in ICU patients. Recent studies suggest that low-dose dexmedetomidine or ketamine/esketamine may improve sleep quality of ICU patients. The purpose of this trial is to observe whether night-time infusion of low-dose dexmedetomidine-esketamine combination can improve sleep structure of patients receiving mechanical ventilation or high-flow nasal cannula oxygen therapy in the ICU.

Timeline

Start
2023-11-01
Primary completion
2025-04-22
Completion
2025-05-23

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified
Subject Esketamine Other / unclassified
Comparator Propofol Small molecule
Comparator Remifentanil Small molecule

Indications